More on DeVry (DV): FQ2 beats on all counts, despite a 3.6% downtick in total sales for the quarter. Net earnings increased five-fold despite the decline in revenue, as impairment charges weighed on year-earlier results. However, declining enrollments continue unabated. Total undergraduate enrollment declined 18% for the November session, while new enrollments fell 16%. Total student enrollment over the same period decreased 12% to 62,899. Shares +13.8% AH.